Position in CGC
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$27,479
-$5,363 QoQ
Shares Held
28,956
+0.5% QoQ
Ownership
0.007%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2025
2 quarters on record
Voting authority
Sole 6.995104461145969.ToString("F0")%
Shared 0.ToString("F0")%
None 93.00489553885403.ToString("F0")%
Common Shares in CGC Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Focus Partners Wealth holds $54,434,760 across 17 Drug Manufacturers - Specialty & Generic names. CGC ranks #17 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
137,784 | $16,287,446 | |
| 2 | NBIX |
Neurocrine Biosciences Inc
|
80,335 | $10,583,332 | |
| 3 | TAK |
Takeda Pharmaceutical Co Ltd
|
482,387 | $8,933,807 | |
| 4 | LNTH |
Lantheus Holdings, Inc.
|
72,517 | $5,500,414 | |
| 5 | UTHR |
UNITED THERAPEUTICS Corp
|
5,854 | $3,471,304 | |
| 6 | ALKS |
Alkermes plc.
|
77,052 | $2,724,558 | |
| 7 | HLN |
Haleon plc
|
195,548 | $1,957,435 | |
| 8 | VTRS |
Viatris Inc
|
132,034 | $1,783,779 |
All Filings in CGC
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $27,479 | 28,956 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $32,842 | 28,809 | Shares | Sole | 2026-02-13 | |
| No filing history on record for this holder in this stock. | ||||||